These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 10632037
1. Benzimidazole derivatives. Part 1: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 receptor antagonists. López-Rodríguez ML, Benhamú B, Viso A, Morcillo MJ, Murcia M, Orensanz L, Alfaro MJ, Martín MI. Bioorg Med Chem; 1999 Nov; 7(11):2271-81. PubMed ID: 10632037 [Abstract] [Full Text] [Related]
2. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives. Tapia I, Alonso-Cires L, López-Tudanca PL, Mosquera R, Labeaga L, Innerárity A, Orjales A. J Med Chem; 1999 Jul 29; 42(15):2870-80. PubMed ID: 10425096 [Abstract] [Full Text] [Related]
3. Benzimidazole derivatives. 2. Synthesis and structure-activity relationships of new azabicyclic benzimidazole-4-carboxylic acid derivatives with affinity for serotoninergic 5-HT(3) receptors. López-Rodríguez ML, Benhamú B, Morcillo MJ, Tejada ID, Orensanz L, Alfaro MJ, Martín MI. J Med Chem; 1999 Dec 02; 42(24):5020-8. PubMed ID: 10585211 [Abstract] [Full Text] [Related]
4. Benzimidazole derivatives. 4. The recognition of the voluminous substituent attached to the basic amino group of 5-HT4 receptor antagonists. López-Rodríguez ML, Benhamú B, Murcia M, Alvaro E, Campillo M, Pardo L. J Comput Aided Mol Des; 2003 Aug 02; 17(8):515-24. PubMed ID: 14703122 [Abstract] [Full Text] [Related]
5. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives. Schaus JM, Thompson DC, Bloomquist WE, Susemichel AD, Calligaro DO, Cohen ML. J Med Chem; 1998 May 21; 41(11):1943-55. PubMed ID: 9599243 [Abstract] [Full Text] [Related]
10. (R) and (S) RS 56532: mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity. Eglen RM, Bonhaus DW, Clark RD, Johnson LG, Lee CH, Leung E, Smith WL, Wong EH, Whiting RL. Neuropharmacology; 1994 Nov 21; 33(3-4):515-26. PubMed ID: 7984291 [Abstract] [Full Text] [Related]
11. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine. Waikar MV, Hegde SS, Ford AP, Clarke DE. J Pharmacol Exp Ther; 1993 Feb 21; 264(2):654-61. PubMed ID: 8437113 [Abstract] [Full Text] [Related]
12. Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists. Turconi M, Nicola M, Quintero MG, Maiocchi L, Micheletti R, Giraldo E, Donetti A. J Med Chem; 1990 Aug 21; 33(8):2101-8. PubMed ID: 1695682 [Abstract] [Full Text] [Related]
17. Arylcarbamate derivatives of 1-piperidineethanol as potent ligands for 5-HT4 receptors. Soulier JL, Yang D, Brémont B, Croci T, Guzzi U, Langlois M. J Med Chem; 1997 May 23; 40(11):1755-61. PubMed ID: 9171886 [Abstract] [Full Text] [Related]